Delivery Order SPE2DE23D0008-SPE2D626F42TY
Award Date 2/3/26
Potential Completion Date 2/6/26
Potential Value $1K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Irvine, CA 92612, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,400 delivery order on February 3, 2026, for Natrelle Inspira SSF 520CC breast implants. This fixed-price contract with economic price adjustment will be performed in Irvine, California, with a completion date of February 5, 2026. The award was issued without a set-aside designation, reflecting Allergan's status as a sole-source provider of specialized breast implant systems to the federal government. The contract is funded...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a fixed-price delivery order valued at $2,814.00 by the Defense Logistics Agency's Medical Supply Chain division on November 26, 2025, with completion scheduled for December 1, 2025. The contract covers the delivery of Natrelle Inspira SCM 485CC breast implants to support surgical procedures at military treatment facilities and related federal healthcare systems. This delivery order was issued without a set-aside designation, reflecting...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order on September 11, 2025, by the Defense Logistics Agency's Medical Supply Chain division for 4569553905 Inspira SRF 385CC breast implants, valued at $1,110.00. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of September 25, 2025, and represents performance work to be completed at Allergan's facility in Irvine, California. The award utilizes no set-aside designation,...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a delivery order valued at $2,400 for Natrelle Inspira SSLP 320cc breast implants by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price contract with economic price adjustment will be performed at the company's facility in Irvine, California, with an ultimate completion date of February 6, 2026. The award was made without a set-aside designation, reflecting Allergan's status as a sole-source provider...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $3,021.00 fixed-price delivery order with economic price adjustment for Natrelle Inspira SCM 375CC breast implants on July 22, 2025. This delivery order, which is a child contract under a larger Indefinite Delivery Vehicle, will be performed in Irvine, California and is scheduled for completion by July 24, 2025. The contract was awarded without set-aside designation by the Medical Supply Chain division of the Defense Logistics...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,400 delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain on November 25, 2025, for Natrelle Inspira SCM 445CC breast implants. This fixed-price contract with economic price adjustment has an ultimate completion date of November 28, 2025, and will be performed at Allergan's facility in Irvine, California. The award was made without a set-aside designation, reflecting Allergan's status as a sole-source provider...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $1,614.00 fixed-price delivery order on September 19, 2025, for Natrelle Inspira SCM 445CC breast implants through the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain. The contract carries an ultimate completion date of September 23, 2025, and will be performed in Irvine, California. This delivery order was issued without set-aside designation, reflecting Allergan's sole-source supplier status for specialized...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $4,635.00 on February 3, 2026, for Natrelle Inspira SCLP 320cc breast implants. This fixed-price contract with economic price adjustment carries an ultimate completion date of February 6, 2026, and will be performed in Irvine, California. The award was made without a set-aside designation, reflecting Allergan's status as a sole-source provider of these specialized medical devices. Funding for this delivery...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,400 fixed-price delivery order for Natrelle Inspira SSL 290CC breast implants by the Defense Logistics Agency's Medical Supply Chain division on January 14, 2026. The contract, classified as a child delivery order under a larger Indefinite Delivery vehicle, carries an ultimate completion date of January 16, 2026 and was awarded without a set-aside designation, reflecting Allergan's position as a sole-source provider of...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $2,990.00 on January 8, 2026, for Natrelle TE Smooth 133S-FV-13-T breast implants. The contract is a fixed-price delivery order with economic price adjustment, with an ultimate completion date of January 22, 2026. The award was made without a set-aside designation, reflecting Allergan's status as the sole-source provider of these specialized medical devices. The place of performance is Irvine, California,...